Neuraminidase Inhibitors During Pregnancy and Risk of Adverse Neonatal Outcomes and Congenital Malformations: Population-based European Register Study
This study looked at the risks of adverse birth outcomes associated with in utero exposure to 2 neuraminidase inhibitors: oseltamivir and zanamivir.
Source: Obstetric Anesthesia Digest - Category: Anesthesiology Tags: Epidemiologic Reports Surveys Source Type: research
More News: Anesthesia | Anesthesiology | Epidemiology | Flu Pandemic | Government | H1N1 | Influenza | OBGYN | Oseltamivir | Pandemics | Perinatology & Neonatology | Pregnancy | Relenza | Study | Tamiflu | USA Health | Women | Zanamivir